Health & Biotech
Check out the latest Health news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Dimerix first patient completes Phase 3 trial and enters into long-term DMX-200 Open Label Extension study
Health & Biotech
Bio Curious: Nerve repair house plans to break the IPO drought
Health & Biotech
Alive and Kicking: Pot stock Argent Biopharma aims to raise bar on epilepsy treatment
Health & Biotech
Control Bionics inks UK and Ireland distribution deal for NeuroNode
Health & Biotech
Neurotech’s cannabinoid drug reverses immune dysregulation in PANDAS/PANS kids
Stockhead TV
Break it Down: Neurotech gives something to think about
Health & Biotech
Dr Boreham’s Crucible: It didn’t take an Einstein to figure out this biotech needed a new strategy. But there’s hope yet
Aftermarket
1 in 3 singles never use contraception during sex (and yes it’s time to panic)
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in ‘lacklustre’ week
Health & Biotech
Orthocell’s collagen-membrane dental-regeneration product Striate+ debuts in Canada
Stockhead TV
Break it Down: Orthocell smiles on key sales
Health & Biotech
Long Shortz: Race Oncology’s boardroom renewal
Health & Biotech
Twiggy’s Tenmile to become largest shareholder of Lumos Diagnostics
Health & Biotech
Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval
Health & Biotech
Here’s cheers – Calmer Co capitalises on Kava trend
Health & Biotech
Alive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raise
Health & Biotech
Dr Boreham’s Crucible: Diverse ASX biotech gun Telix brushes off suggestions it’s peaked
Experts
CRITERION: Opportunity knocks for some amid crackdown on NDIS fraud
Aftermarket
Research suggests men’s cancer risk will rise by 84% by 2050
Health & Biotech
Neurotech chases another orphan drug designation
Health & Biotech
‘Significant milestone’ – EBR submits final PMA module to FDA
Health & Biotech
TrivarX’s AI is screening for depression by monitoring sleep
Stockhead TV
Long Shortz with Bioxyne: It’s all go for gummies made yummy with cannabis in Aussie first
Health & Biotech
Morgans sees big upside for PharmAust if monepantel succeeds
Health & Biotech
EZZ lifts on record revenue of $66.4m in FY24
Health & Biotech
Health Kick Podcast: Creating hope for debilitating diseases
Health & Biotech
PharmAust reports positive interim results of OLE study on monepantel to treat ALS
Health & Biotech
Lumos Diagnostics seals deal to advance point-of-care test to monitor liver health
Health & Biotech
Tryptamine completes world-first Phase 1b psilocin IV-infusion trial
Stockhead TV
Long Shortz with Control Bionics: Major MedTech milestone with new US recognition
Health & Biotech
HealthInvest 2024 set to show off latest ASX healthcare innovators
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Stockhead TV
Long Shortz with LTR Pharma: Erectile dysfunction help just a spray away
Stockhead TV
Break it Down: Bioxyne goes gummy gaga in Australian first
Health & Biotech
Bioxyne sweetens the pot as Australia’s first manufacturer of pharmaceutical cannabis gummies
Health & Biotech
Aroa advances clinical evidence for soft tissue repair products
Experts
Dr Boreham’s Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Health & Biotech
Optiscan joins with US uni to improve cancer detection in animals
Aftermarket
These are the top 10 causes of death around the world
Health & Biotech
ASX Health Stocks: Lift off for LTR Pharma’s ED therapy under TGA scheme
Health & Biotech
BlinkLab smartphone platform could transform autism and ADHD diagnosis
Health & Biotech
Air supply: The ASX medtechs tackling respiratory illnesses
Health & Biotech
LTP enters deal with Aptar Pharma to develop Spontan nasal spray
Stockhead TV
Long Shortz with Tryptamine Therapeutics: Fantastic fibromyalgia results off the back of US psychedelic trial
Health & Biotech
ASX medtechs at heart of growing cardiac care market
Health & Biotech
Neurotech focuses on global partnerships and Aussie registration
Stockhead TV
Break it Down: Tryptamine Therapeutics’ rad results for Fibromyalgia patients
Load More